Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4):395–403. doi: 10.1016/j.japh.2018.03.005

Table 3.

Overview of Brief Motivational Intervention-Medication Therapy Management

Interventionist/
education
Overarching
Intervention
Component
Session Content
PharmD level pharmacist Medication Therapy Management Reviewing the opioid medication(s) being taken
Discussing misuse screening results
Exploring behaviors indicative of misuse (e.g., early refills, taking medications too often/higher dosages than prescribed)
Identifying/documenting possible targets for adherence improvement.
Brief Motivational Intervention Facilitating a non-directive discussion regarding motivation to change
Discussing importance/confidence to avoid misuse
Assisting to resolve ambivalence towards eliminating misuse, and, if appropriate
Referring to treatment, including but not limited to referral to Patient Navigation
Master’s level navigator Patient Navigation and naloxone referral Session 1: development of therapeutic alliance/rapport and goal setting.
Sessions 2–3: identifying barriers and problem resolutions.
Session 4: reviewing overdose prevention tool-kit and referring/directing to a naloxone prescription/training.
Sessions 5–7: encouraging and reinforcing treatment adherence, reviewing and identifying other care needs, and offering linkages to service providers as applicable.
Session8: examines continued challenges to self-care and goals and formulates plans to continue progress